Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Identification and validation of plasma protein biomarkers as therapeutic targets in acute myeloid leukemia: an integrative multi-omics studyIdentification and validation of plasma protein biomarkers as therapeutic targets in acute myeloid leukemia: an integrative multi-omics study

Submitted by Anna Hakala on Tue, 11/11/2025 - 09:59
  • Read more about Identification and validation of plasma protein biomarkers as therapeutic targets in acute myeloid leukemia: an integrative multi-omics studyIdentification and validation of plasma protein biomarkers as therapeutic targets in acute myeloid leukemia: an integrative multi-omics study

Blood metabolites mediate gut microbiota effects on depression: A Mendelian randomization study

Submitted by Anna Hakala on Tue, 11/11/2025 - 09:58
  • Read more about Blood metabolites mediate gut microbiota effects on depression: A Mendelian randomization study

Validity of telephone-administered word list learning measures for assessment of episodic memory in aging and Alzheimer's disease

Submitted by Anna Hakala on Tue, 11/11/2025 - 09:56
  • Read more about Validity of telephone-administered word list learning measures for assessment of episodic memory in aging and Alzheimer's disease

Proteome-wide Mendelian randomization and colocalization analysis uncovers druggable targets for lung cancer across multiple phenotypes and complications

Submitted by Anna Hakala on Tue, 11/11/2025 - 09:54
  • Read more about Proteome-wide Mendelian randomization and colocalization analysis uncovers druggable targets for lung cancer across multiple phenotypes and complications

Deciphering the Role of VIM, STX8, and MIF in Pneumoconiosis Susceptibility: A Mendelian Randomization Analysis of the Lung-Gut Axis and Multi-Omics Insights from European and East Asian Populations

Submitted by Anna Hakala on Tue, 11/11/2025 - 09:50
  • Read more about Deciphering the Role of VIM, STX8, and MIF in Pneumoconiosis Susceptibility: A Mendelian Randomization Analysis of the Lung-Gut Axis and Multi-Omics Insights from European and East Asian Populations

Causal effects of 731 immune cells on post-traumatic stress disorder: A Mendelian randomization study

Submitted by Anna Hakala on Tue, 11/11/2025 - 09:49
  • Read more about Causal effects of 731 immune cells on post-traumatic stress disorder: A Mendelian randomization study

Mendelian Randomization and Bioinformatics Analysis Reveal the Potential Protective Role of Metformin in Primary Liver Cancer

Submitted by Anna Hakala on Tue, 11/11/2025 - 09:46
  • Read more about Mendelian Randomization and Bioinformatics Analysis Reveal the Potential Protective Role of Metformin in Primary Liver Cancer

Causal relationship between albumin, total protein, and colorectal cancer risk: A 2-sample Mendelian randomization study

Submitted by Anna Hakala on Tue, 11/11/2025 - 09:45
  • Read more about Causal relationship between albumin, total protein, and colorectal cancer risk: A 2-sample Mendelian randomization study

Causal relationships between modifiable risk factors and heart failure: A comprehensive Mendelian randomization study

Submitted by Anna Hakala on Tue, 11/11/2025 - 09:44
  • Read more about Causal relationships between modifiable risk factors and heart failure: A comprehensive Mendelian randomization study

Genetic associations with educational fields

Submitted by Anna Hakala on Tue, 11/11/2025 - 09:42
  • Read more about Genetic associations with educational fields

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Current page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement